April 1, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation U.S. FDA Approves Canagliflozin (TA[removed]for the Treatment of Adult Patients with Type 2 Diabetes

First Page		Document Content
Date: 2013-04-01 21:51:25 Diabetes mellitus SLC5A2 Anti-diabetic medication Diabetes Health Medicine		April 1, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation U.S. FDA Approves Canagliflozin (TA[removed]for the Treatment of Adult Patients with Type 2 Diabetes Add to Reading List Source URL: www.mt-pharma.co.jp Download Document from Source Website File Size: 19,62 KB Share Document on Facebook